Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
Aquestive Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Aquestive Therapeutics reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at Aquestive Therapeutics received on average a compensation package of $1.6M, a 42% increase compared to previous year.
Average pay of disclosed executives at Aquestive Therapeutics
Daniel Barber, Chief Executive Officer, received $2.5M in total, which increased by 88% compared to 2022. 57% of Barber's compensation, or $1.4M, was in stock awards. Barber also received $436K in non-equity incentive plan, $600K in salary, as well as $28K in other compensation.
Lori J. Braender, General Counsel, received a compensation package of $1.2M, which increased by 28% compared to previous year. 40% of the compensation package, or $481K, was in stock awards.
A. Ernest Toth, Jr, Chief Financial Officer, earned $1.1M in 2023.
Related executives
You may also like
Source: SEC filing on April 26, 2024.